BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 22783569)

  • 1. CD256 can be found in antibody-mediated renal allograft rejection tissues.
    Xu H; He X; Zhao W; Guo H; Shi Q; Zhu Y; Zhang X
    Clin Lab; 2012; 58(5-6):411-8. PubMed ID: 22783569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APRIL and BAFF proteins increase proliferation of human adipose-derived stem cells through activation of Erk1/2 MAP kinase.
    Zonca M; Mancheño-Corvo P; DelaRosa O; Mañes S; Büscher D; Lombardo E; Planelles L
    Tissue Eng Part A; 2012 Apr; 18(7-8):852-9. PubMed ID: 22059379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of B-cell activating factor belonging to tumor necrosis factor superfamily (BAFF) significantly correlated with C4D in kidney allograft rejection.
    Xu H; He X; Sun J; Shi D; Zhu Y; Zhang X
    Transplant Proc; 2009; 41(1):112-6. PubMed ID: 19249491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion.
    Katsenelson N; Kanswal S; Puig M; Mostowski H; Verthelyi D; Akkoyunlu M
    Eur J Immunol; 2007 Jul; 37(7):1785-95. PubMed ID: 17557373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development.
    Alexaki VI; Notas G; Pelekanou V; Kampa M; Valkanou M; Theodoropoulos P; Stathopoulos EN; Tsapis A; Castanas E
    J Immunol; 2009 Nov; 183(9):5948-56. PubMed ID: 19828625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased BCMA expression in lupus marks activated B cells, and BCMA receptor engagement enhances the response to TLR9 stimulation.
    Kim J; Gross JA; Dillon SR; Min JK; Elkon KB
    Autoimmunity; 2011 Mar; 44(2):69-81. PubMed ID: 21250838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-cell maturation antigen (BCMA) activation exerts specific proinflammatory effects in normal human keratinocytes and is preferentially expressed in inflammatory skin pathologies.
    Alexaki VI; Pelekanou V; Notas G; Venihaki M; Kampa M; Dessirier V; Sabour-Alaoui S; Stathopoulos EN; Tsapis A; Castanas E
    Endocrinology; 2012 Feb; 153(2):739-49. PubMed ID: 22166983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling pathways for B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) in human placenta.
    Langat DL; Wheaton DA; Platt JS; Sifers T; Hunt JS
    Am J Pathol; 2008 May; 172(5):1303-11. PubMed ID: 18403603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop.
    Moreaux J; Sprynski AC; Dillon SR; Mahtouk K; Jourdan M; Ythier A; Moine P; Robert N; Jourdan E; Rossi JF; Klein B
    Eur J Haematol; 2009 Aug; 83(2):119-29. PubMed ID: 19456850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortiz-Lazareno PC; Cruz A; Oregon-Romero E; Machado-Contreras JR; Muñoz-Valle JF; Orozco-López M; Marín-Rosales M; Palafox-Sánchez CA
    Lupus; 2016 May; 25(6):582-92. PubMed ID: 26424128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF.
    Abu-Rish EY; Amrani Y; Browning MJ
    Rheumatology (Oxford); 2013 Jul; 52(7):1190-201. PubMed ID: 23436580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the Role of BAFF and Its Receptors in Renal Transplant Recipients with Chronic Antibody-Mediated Rejection.
    Afzali S; Salehi S; Shahi A; Esmaeili M; Farashi Bonab S; Peykari A; Bagherpour F; Ansaripour B; Soleimanian T; Pour-Reza-Gholi F; Amirzargar A
    J Immunol Res; 2021; 2021():6654992. PubMed ID: 33748289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome.
    Daridon C; Devauchelle V; Hutin P; Le Berre R; Martins-Carvalho C; Bendaoud B; Dueymes M; Saraux A; Youinou P; Pers JO
    Arthritis Rheum; 2007 Apr; 56(4):1134-44. PubMed ID: 17393395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BAFF, a newcomer to the lupus party.
    Binard A; Youinou P
    Lupus; 2007; 16(9):699-700. PubMed ID: 17728361
    [No Abstract]   [Full Text] [Related]  

  • 15. TACI-dependent APRIL signaling maintains autoreactive B cells in a mouse model of systemic lupus erythematosus.
    Tran NL; Schneider P; Santiago-Raber ML
    Eur J Immunol; 2017 Apr; 47(4):713-723. PubMed ID: 28267197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
    Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A
    Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties.
    Mackay F; Schneider P
    Cytokine Growth Factor Rev; 2008; 19(3-4):263-76. PubMed ID: 18514565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BAFF, APRIL, TWEAK, BCMA, TACI and Fn14 proteins are related to human glioma tumor grade: immunohistochemistry and public microarray data meta-analysis.
    Pelekanou V; Notas G; Kampa M; Tsentelierou E; Stathopoulos EN; Tsapis A; Castanas E
    PLoS One; 2013; 8(12):e83250. PubMed ID: 24376672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
    Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency.
    Lee JJ; Ozcan E; Rauter I; Geha RS
    Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):520-6. PubMed ID: 18978466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.